Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 31;71(11):3012-3013.
doi: 10.1093/cid/ciaa278.

Influenza Challenge Models: Ready for Prime Time?

David I Bernstein  1 , Robert L Atmar  2 , Daniel F Hoft  3
Affiliations
Comment

Influenza Challenge Models: Ready for Prime Time?

David I Bernstein et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Bernstein, Atmar, and Hoft.
    Han A, Taubenberger JK, Memoli MJ. Han A, et al. Clin Infect Dis. 2020 Dec 31;71(11):3013-3014. doi: 10.1093/cid/ciaa279. Clin Infect Dis. 2020. PMID: 32206777 Free PMC article. No abstract available.

Comment on

References

    1. Han A, Czajkowski LM, Donaldson A, et al. . A dose-finding study of a wild-type influenza A(H3N2) virus in a healthy volunteer human challenge model. Clin Infect Dis 2019; 69:2082–90. - PMC - PubMed
    1. Memoli MJ, Czajkowski L, Reed S, et al. . Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study. Clin Infect Dis 2015; 60:693–702. - PMC - PubMed
    1. Memoli MJ, Han A, Walters KA, et al. . Influenza A reinfection in sequential human challenge: implications for protective immunity and “universal” vaccine development. Clin Infect Dis 2020; 70:748–53. - PMC - PubMed
    1. Han A, Poon JL, Powers JH 3rd, Leidy NK, Yu R, Memoli MJ. Using the influenza patient-reported outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model. BMC Infect Dis 2018; 18:353. - PMC - PubMed
    1. Reuman PD, Bernstein DI, Keefer MC, Young EC, Sherwood JR, Schiff GM. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res 1989; 11:27–40. - PubMed